Characteristics of individuals with breast cancer rearrangements in BRCA1 and BRCA2

Large rearrangements in BRCA1 and BRCA2 occur in a small percentage (< 1%) of patients tested for hereditary breast (BC) and ovarian cancer. It is unclear what factors predict BRACAnalysis Large Rearrangement Test (BART) positivity.

[1]  C. Vachon,et al.  Genetic susceptibility to triple-negative breast cancer. , 2013, Cancer research.

[2]  E. John,et al.  Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  E. Rosenthal,et al.  Clinical significance of large rearrangements in BRCA1 and BRCA2 , 2012, Cancer.

[4]  G. Parmigiani,et al.  The penetrance of ductal carcinoma in situ among BRCA1 and BRCA2 mutation carriers , 2012, Breast Cancer Research and Treatment.

[5]  Jenny Chang-Claude,et al.  Comparison of Different Haplotype-Based Haplotype-Based Association Methods for Gene-Environment (G×E) Interactions in Case-Control Studies when Haplotype-Phase Is Ambiguous , 2009, Human Heredity.

[6]  Nengjun Yi,et al.  Hierarchical Generalized Linear Models for Multiple Quantitative Trait Locus Mapping , 2009, Genetics.

[7]  M. G. Pittau,et al.  A weakly informative default prior distribution for logistic and other regression models , 2008, 0901.4011.

[8]  W. Foulkes,et al.  Hereditary breast cancer: new genetic developments, new therapeutic avenues , 2008, Human Genetics.

[9]  N. Yi,et al.  Bayesian LASSO for Quantitative Trait Loci Mapping , 2008, Genetics.

[10]  Ewout W Steyerberg,et al.  The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases , 2007, Genetics in Medicine.

[11]  G. Tomlinson,et al.  Evidence for Common Ancestral Origin of a Recurring BRCA1 Genomic Rearrangement Identified in High-Risk Hispanic Families , 2007, Cancer Epidemiology Biomarkers & Prevention.

[12]  L. Esserman,et al.  Ductal carcinoma in situ in BRCA mutation carriers. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  L C Kwee,et al.  Simple methods for assessing haplotype‐environment interactions in case‐only and case‐control studies , 2007, Genetic epidemiology.

[14]  T. Walsh,et al.  Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. , 2006, JAMA.

[15]  Sven Cichon,et al.  Haplotype interaction analysis of unlinked regions , 2005, Genetic epidemiology.

[16]  N. Laird,et al.  Estimation and Tests of Haplotype-Environment Interaction when Linkage Phase Is Ambiguous , 2003, Human Heredity.

[17]  G R Taylor,et al.  The detection of large deletions or duplications in genomic DNA , 2002, Human mutation.